Amyloid-PET and 18F-FDG-PET in the diagnostic investigation of Alzheimer's disease and other dementiasGaël Chételat, Alexander Drzezga, Javier Arbizu et al.|The Lancet Neurology|2020Cited by 535
Plasma p-tau217 and tau-PET predict future cognitive decline among cognitively unimpaired individuals: implications for clinical trialsRik Ossenkoppele, Oskar Hansson, Sebastian Palmqvist et al.|Nature Aging|2025Cited by 68
PET Imaging and Protein Expression of Prostate-Specific Membrane Antigen in Glioblastoma: A Multicenter Inventory StudySanne A. M. van Lith, Elsmarieke van de Giessen|Journal of Nuclear Medicine|2023Cited by 17